ArticleJournal of clinical neurology (Seoul, Korea)2025
Comparing Lesion Volume Dynamics Between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder During Remission Using Machine-Learning Segmentation.
Article in Journal of clinical neurology (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence That Changes Clinical Neurology Practice: Translating Algorithms Into Actionable Care.Journal of clinical neurology (Seoul, Korea) · 2026Review
- Astrocyte Heterogeneity in Multiple Sclerosis From Reactive Glia to Therapeutic Targets.Journal of clinical neurology (Seoul, Korea) · 2026Article
- Multimodal MRI biomarkers and machine learning in neuromyelitis optica spectrum disorder: a review.Frontiers in neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
background and purposeMultiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are inflammatory demyelinating conditions of the central nervous system that have distinct pathological mechanisms. There is a paucity of studies comparing the accumulation of subclinical lesions between MS and NMOSD, especially during the clinical remission period. Recent advances in neuroimaging techniques, those particularly involving the use of machine learning (ML) methods for lesion segmentation, have provided new opportunities to quantitatively assess the volumes of brain lesions and how they change over time. In this study, we aimed to use ML-based lesion segmentation methods to measure differences in lesion volumes and their changes during the remission period between patients with MS and NMOSD.
methodsThis study included a retrospective cohort of 31 patients with MS and patients with 30 aquaporin-4-positive (AQP4⁺) NMOSD from the National Cancer Center registry. Serial 3D brain magnetic resonance imaging (MRI) scans obtained during the interattack period were analyzed using ML-based segmentation. MRI data preprocessing included alignment, distortion correction, and normalization, with lesion mapping and statistical analyses determining changes in lesion volumes.
resultsThe MS patients exhibited significant increases in the median lesion volume (from 3,493 mm³ to 4,430 mm³,
conclusionsThese findings highlight the distinct pathogenic processes of the two conditions and hence the need for specialized therapeutic and monitoring strategies for patients with MS and AQP4⁺ NMOSD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.